ABOUT
Qerity is a private firm providing specialized advisory and management services in precision medicine with a focus on development and commercialization of companion diagnostics in support of targeted therapeutic assets. The firm was founded in 2008 under the name Genecept and has advised dozens of clients including drug developers, IVD manufacturers and specialty laboratories to achieve success for their products and services in this challenging and dynamic space.
David M Jackson PhD
Founder and Principal
David has provided CDx advisory services to dozens of clients. He has worked for drug developers, IVD manufacturers and specialty laboratories in the CDx space.
Throughout his career, David has served as a member of senior leadership for a variety of medical device and pharmaceutical firms. He frequently assists young companies through interim management throughout various stages of financing to exit design. His broad network affords uniquely unbiased and comprehensive insights into best practices and effective solutions for Qerity's clients.
Qerity Support Team
Qerity deploys subject matter experts in CDx regulatory science, clinical operations, program development, and commercial strategy for clients.
These individuals contribute to the development of state-of-the-art strategies, project oversight and business solutions for clients.
